NCT07716449 — Gastric or Gastroesophageal Junction Adenocarcinoma trial site landscape

Public-registry site landscape for NCT07716449, a Gastric or Gastroesophageal Junction Adenocarcinoma study sponsored by Qilu Pharmaceutical Co., Ltd.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07716449 (registry record)
Sponsor	Qilu Pharmaceutical Co., Ltd.
Condition(s)	Gastric or Gastroesophageal Junction Adenocarcinoma
Phase	PHASE3
Listed sites	0

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07716449 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.